Health

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial – The Lancet

Among patients with non-severe COVID-19 and no risk factors for severe disease receivinga single 400 mcg/kg dose of ivermectin within 72 h of fever or cough onset…

Published

5 years ago

January 19, 2021

Noosa Online News Publisher

[1].WHO. COVID-19 Weekly epidemiological update – 15 December 2020. Available at https://www.who.int/publications/m/item/weekly-epidemiological-update15-december-2020 (Accessed December 21, 2020).

[2].Difficult to determine herd immunity threshold for COVID-19.
JAMA.2020; 324: 732

[3].COVID-19 herd immunity: where are we?.
Nat Rev Immunol.2020; 20: 583-584

[4].WHO. Newsroom – coronavirus disease (COVID-19): vaccines. Available at https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines…

Click here to view the original article.

Related Topics:Australia The Lancet

Up Next

A new COVID-19 challenge: Mutations rise along with cases – Egypt Independent

Don't Miss

Getting under your skin: Molecular research builds new understanding of skin regeneration – EurekAlert

Noosa News11 hours ago

Mega-team of heavy horses sets world record at Good Old Days Festival

General15 hours ago

English springer spaniels Kelly and Milo helping fight dieback in Western Australia

General14 hours ago

Homicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba

Noosa News4 hours ago

NRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership

Noosa Online News

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial – The Lancet

Trending